Episode 041: Myeloma Series, Pt.2 - Intro to MGUS and Smoldering Myeloma
The Fellow on Call: The Heme/Onc Podcast
00:00
The Slim Criteria for Myeloma Treatment
The slim criteria were found to portend a very high risk of progression to overt myeloma. About 80% at two years, which is why we're now considering it sort of morally equivalent to overt Myeloma. The idea being that we can have an opportunity to treat these patients with myeloma treatment before they develop the end organ damage evident in crab criteria.
Transcript
Play full episode
